E&L Data Integrity: Raw Data, Unknowns, and Toxicology Traceability


Published on 03/05/2026

Addressing Concerns with Extractables and Leachables Studies in Pharma Manufacturing

In pharmaceutical manufacturing, ensuring the integrity and safety of drug products is paramount. One major aspect of this is managing the risks associated with extractables and leachables (E&L). If your facility notices discrepancies in the E&L data or an increase in product complaints linked to chemical migration, you could be facing contamination or compliance challenges. This article offers a structured approach to investigate and resolve issues related to E&L studies, enabling you to enhance data integrity and ensure regulatory compliance.

After reading this article, you will have the tools to identify symptoms on the manufacturing floor, understand possible causes, implement immediate containment actions, and establish a robust corrective and preventive action (CAPA) strategy tailored for E&L issues.

Symptoms/Signals on the Floor or in the Lab

Symptoms indicating potential E&L-related issues may vary from unusual lab results to customer complaints. Common symptoms include:

  • Increased Unknown Peaks: The presence of unexpected peaks in chromatographic analyses may suggest contamination from the packaging materials.
  • Product Complaints: Reports of adverse effects or
changes in product stability can signal failure in packaging integrity.
  • Variability in Stability Results: Unexplained deviations in stability data, especially during long-term studies, can indicate leachables that affect product efficacy.
  • Failed Toxicology Thresholds: Detecting substances above established safety thresholds during E&L testing should prompt immediate investigation.
  • Likely Causes

    Understanding the underlying causes for E&L issues is key. These causes can generally be categorized into materials, methods, machines, human factors, measurement, and environmental conditions:

    Category Likely Cause
    Materials Inadequate selection of packaging materials that yield high extractables.
    Method Inappropriate analytical methods leading to incomplete characterizations.
    Machine Improper equipment calibration affecting extraction conditions.
    Man Lack of trained personnel resulting in non-compliance with E&L protocols.
    Measurement Deficient analytical validation leading to questionable test results.
    Environment Suboptimal environmental controls leading to cross-contamination.

    Immediate Containment Actions (first 60 minutes)

    When an E&L issue is detected, immediate containment is crucial. Actions to consider in the first hour include:

    • Cease Product Packaging: Halt all operations involving suspected materials to mitigate any further contamination risks.
    • Isolate Affected Batches: Place quarantined products and materials aside to prevent accidental distribution.
    • Notify Quality Assurance (QA): Initiate a notification to the QA team to begin a formal investigation.
    • Document the Incident: Record timestamps, conditions observed, and any immediate actions taken.

    Investigation Workflow

    A systematic investigation workflow is essential to address E&L issues effectively. Here are the key steps:

    1. Gather Data: Collect all relevant data, including batch records, E&L test results, and environmental monitoring reports.
    2. Interview Personnel: Speak with those involved in the affected batch production to gather insights on processes and deviations.
    3. Review Historical Data: Compare historical E&L data against the current findings to identify trends or anomalies.
    4. Analyze Production Process: Assess production conditions, including equipment used and environmental controls.

    Ensure that all collected data includes sufficient detail for interpretation during the root cause analysis phase.

    Root Cause Tools

    Various root cause analysis tools can be employed to identify the fundamental issues leading to E&L problems. The selection of the tool depends on the complexity and nature of the investigation:

    • 5-Why Analysis: Effective for simple problems; start with the problem and ask “why” successively until the root cause is identified.
    • Fishbone Diagram: Useful for categorizing potential causes (Man, Machine, Method, etc.) in more complex scenarios where multiple factors could contribute to the E&L issues.
    • Fault Tree Analysis: A systematic approach to identifying the root cause by mapping potential failures and their causes.

    CAPA Strategy

    A comprehensive CAPA strategy includes three key components:

    • Correction: Implement immediate actions to rectify specific issues found (e.g., recalibrating equipment).
    • Corrective Action: Develop long-term solutions to eliminate root causes, such as revisiting material selection processes.
    • Preventive Action: Establish preventive measures, including enhanced training and regular audits of E&L protocols.

    Document each action and assess its effectiveness through follow-up evaluations and monitoring.

    Control Strategy & Monitoring

    Establishing a robust control strategy for E&L involves continuous monitoring and trending of data:

    • Statistical Process Control (SPC): Use SPC techniques to monitor key parameters that may influence E&L outcomes.
    • Regular Sampling: Enforce a routine sampling plan to analyze batches before release for potential E&L-related contaminants.
    • Alarms and Alarms Triggers: Set up alarm thresholds for levels of extractables and leachables to ensure automatic alerts when results breach acceptable limits.

    Validation / Re-qualification / Change Control Impact

    Changes made to the packaging systems or methodologies influenced by E&L findings necessitate careful validation and change control practices. This includes:

    • Validation Activities: Ensure all new materials undergo proper E&L validation before use.
    • Re-qualification: Regularly re-qualify critical equipment involved in the E&L process to ensure continued compliance.
    • Change Control Procedures: Implement robust change control measures that include reassessing E&L impact for any process or material change.

    Inspection Readiness: What Evidence to Show

    Being inspection-ready means having organized and accurate documentation to showcase compliance during audits. Key evidence includes:

    Related Reads

    • Batch Records: Detailed batch production records should be readily available, including notes on E&L testing.
    • Testing Logs: Maintain comprehensive records of E&L test results and supporting analytical documentation.
    • Deviation Reports: Document deviations encountered, including any CAPA actions taken in response.

    Ensure that records are traceable and easy to navigate for inspection by regulatory authorities.

    FAQs

    What are extractables and leachables?

    Extractables are compounds that can be extracted from packaging under certain conditions, while leachables are those that migrate into the drug product during storage or use.

    Why are E&L studies essential?

    E&L studies are crucial for ensuring that drug products remain safe and effective, preventing potential adverse effects due to chemical migration from packaging.

    What methods are used in E&L testing?

    E&L testing typically employs methods like gas chromatography, mass spectrometry, and liquid chromatography to identify and quantify contaminants.

    How often should E&L studies be performed?

    E&L studies should be completed for new packaging systems, or whenever significant changes are made to materials or processes.

    What are toxicology thresholds?

    Toxicology thresholds are limits established for specific substances above which the contaminants could pose a risk to human health.

    What is a packaging risk assessment?

    A packaging risk assessment examines the potential risks related to extractables and leachables based on the materials used and the drug product characteristics.

    How can I improve E&L study reliability?

    Improving E&L study reliability involves selecting suitable materials, adhering to validated testing protocols, and implementing rigorous quality control measures.

    What documentation is required for E&L compliance?

    Documentation needed includes testing protocols, results, batch records, and deviation reports, ensuring traceability throughout the process.

    What should be done if E&L levels exceed acceptable limits?

    Immediate containment actions should be executed, followed by a thorough investigation to identify root causes and implement CAPA measures accordingly.

    Can environmental factors affect E&L results?

    Yes, environmental factors such as temperature, humidity, and exposure to light can influence the stability and migration of leachables.

    How do regulatory bodies view E&L studies?

    Regulatory bodies like the FDA and EMA require strict adherence to E&L protocols as part of ensuring the safety and efficacy of pharmacological products.

    Pharma Tip:  E&L Studies for High-Dose and Chronic Use Products